An anticancer drug suppresses the primary nucleation reaction that initiates the production of the toxic Aβ42 aggregates linked with Alzheimer's disease (Q36593553)
Jump to navigation
Jump to search
scientific article published on 12 February 2016
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | An anticancer drug suppresses the primary nucleation reaction that initiates the production of the toxic Aβ42 aggregates linked with Alzheimer's disease |
scientific article published on 12 February 2016 |
Statements
1 reference
An anticancer drug suppresses the primary nucleation reaction that initiates the production of the toxic Aβ42 aggregates linked with Alzheimer's disease (English)
1 reference
Christopher M Dobson
1 reference
Michele Vendruscolo
1 reference
Johnny Habchi
1 reference
Paolo Arosio
1 reference
Michele Perni
1 reference
Sean Chia
1 reference
Samuel I A Cohen
1 reference
Martin B D Müller
1 reference
Ellen A A Nollen
1 reference
Tuomas P J Knowles
1 reference
Identifiers
1 reference